27
Dravite Therapeutics, Inc. files Form D
Company raise update · Closed · Offering $15M · Sold $15M · SAN FRANCISCO, CA · filed 2026-07-28
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| RISHI GUPTA | Director |
| MATTHEW MOORE | Executive Officer, Director |
| JOSEPH SUM | Executive Officer, Director |
| BARBARA KOSACZ | Director |
| SANDEEP KULKARNI | Director |
| JEREMY GOLDBERG | Director |
Signed by Matthew Moore, President and CEO.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.